価格表

在庫・価格 : 2024年05月02日 15時49分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Amphiregulin, Human, ELISA Kit, Quantikine
データシート※最新のデータシートでない場合があります
DAR00 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥116,000 1個 追加

在庫・価格 : 2024年05月02日 15時49分 現在

Amphiregulin, Human, ELISA Kit, Quantikine

  • 商品コード:DAR00
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥116,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Zhang Z et al. Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype. Cancer Res. 2014 May;74(10):2869-81
Zhang Z et al
2014/01/01
Sample Type: cell supernates PubMed
2 Yonesaka K et al. Circulating hepatocyte growth factor is correlated with resistance to cetuximab in metastatic colorectal cancer. Anticancer Res. 2015 Mar;35(3):1683-9
Yonesaka K et al
2015/01/01
Sample Type: Plasma PubMed
3 Trussoni CE et al. Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR). PLoS ONE 2015;10(4):e0125793
Trussoni CE et al
2015/01/01
Sample Type: Cell Culture Supernates PubMed
4 Holtan SG et al. Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. Blood 2016 Nov;128(19):2350-2358
Holtan SG et al
2016/01/01
Sample Type: Plasma PubMed
5 Alvarado D et al. ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC. PLoS ONE 2017;12(7):e0181356
Alvarado D et al
2017/01/01
PubMed
6 Jia J et al. Yes-associated protein promotes the abnormal proliferation of psoriatic keratinocytes via an amphiregulin dependent pathway. Sci Rep 2018 Oct;8(1):14513
Jia J et al
2018/01/01
PubMed
7 Xu Q et al. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression. Aging Cell 2019 12;18(6):e13027
Xu Q et al
2019/01/01
PubMed
8 M辿sange P et al. Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of <i>RAS</i> Status. Clin Cancer Res 2018 06;24(11):2548-2558
M辿sange P et al
2018/01/01
PubMed
9 Wiedemann A et al. Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nat Commun 2020 07;11(1):3730
Wiedemann A et al
2020/01/01
Species: Human PubMed
10 Wang L et al. AREG mediates the epithelial&#x2011;mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF&#x2011;&#x3BA;B signalling pathway. Oncol Rep 2020 May;43(5):1558-1568
Wang L et al
2020/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Zhang Z et al. Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype. Cancer Res. 2014 May;74(10):2869-81
    Zhang Z et al
    2014/01/01
  • 備考:
    Sample Type: cell supernates
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yonesaka K et al. Circulating hepatocyte growth factor is correlated with resistance to cetuximab in metastatic colorectal cancer. Anticancer Res. 2015 Mar;35(3):1683-9
    Yonesaka K et al
    2015/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Trussoni CE et al. Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR). PLoS ONE 2015;10(4):e0125793
    Trussoni CE et al
    2015/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Holtan SG et al. Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. Blood 2016 Nov;128(19):2350-2358
    Holtan SG et al
    2016/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Alvarado D et al. ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC. PLoS ONE 2017;12(7):e0181356
    Alvarado D et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Jia J et al. Yes-associated protein promotes the abnormal proliferation of psoriatic keratinocytes via an amphiregulin dependent pathway. Sci Rep 2018 Oct;8(1):14513
    Jia J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Xu Q et al. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression. Aging Cell 2019 12;18(6):e13027
    Xu Q et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    M辿sange P et al. Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of <i>RAS</i> Status. Clin Cancer Res 2018 06;24(11):2548-2558
    M辿sange P et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wiedemann A et al. Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nat Commun 2020 07;11(1):3730
    Wiedemann A et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Wang L et al. AREG mediates the epithelial&#x2011;mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF&#x2011;&#x3BA;B signalling pathway. Oncol Rep 2020 May;43(5):1558-1568
    Wang L et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed